Global real estate management and development company Brookfield Properties recently announced it will lease parking lot space at 73 of its mall properties to Collection Sites, a QuestCap subsidiary, to use as COVID-19 “pop-up” testing sites, Bisnow reports. The parking lot leases will cover spaces measuring 50 feet by 100 feet and will last for four months initially.
Collection Sites’ COVID-19 tests will cost $59 to $139, but will deliver results in 24 hours through the RT-PCR method. These testing sites will also try to offer antibody and antigen testing, which take eight to 10 minutes to administer, if available. Test results can be shared by text message or email and can come with a certificate of good health with a HIPPA-compliant smartphone app.
“We are excited to add another well-respected company to our list of COVID-19 testing partners in the fight to restore everyday life,” QuestCap CEO Doug Sommerville said in a statement. “It’s known that testing is the key to reducing the spread of the virus; these additional sites will serve to increase access to testing for communities across the US.”
The sites will be in 35 different states and California, Arizona and Texas will be the highest priority states when they roll out this month. Every site is expected to conduct about 150 tests daily. Using retail parking lots as COVID-19 testing sites has been deemed possible since the pandemic hit the U.S., but the rollout didn’t move quickly. It wasn’t until late May when drugstores like Rite Aid and CVS started to do drive-thru testing.
An additional benefit Brookfield could gain from leasing parking lot spaces is generating foot traffic at its malls. The landlord has already had to cut down its retail department because of the COVID-19 pandemics negative impact on shopping malls.
Joe Dyton can be reached at firstname.lastname@example.org.